CTOs on the Move

Neuralstem

www.neuralstem.com

 
Neuralstem is a dual platform regenerative medicine company. The company`s technology enables the production of regionally specific, physiologically relevant neural stem cells for therapeutic use for the treatment of central nervous system (CNS) diseases and has enabled the discovery of a library of patented small molecule neurogenic compounds to treat psychological and cognitive disorders. Neuralstem`s small molecule drug discovery program screens human neural stem cell lines for compounds that may stimulate neurogenesis in the brain, possibly reversing pathologies associated with certain CNS conditions. The company`s lead compound, NSI-189, has completed FDA Phase Ia and Ib safety trials for the treatment of ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.neuralstem.com
  • 20271 Goldenrod Lane 2nd Floor
    Germantown, MD USA 20876
  • Phone: 301.366.4960

Executives

Name Title Contact Details

Similar Companies

Columbus Area

Columbus Area is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

ZERO - The End of Prostate Cancer

ZERO - The End of Prostate Cancer is a 501 non-profit organization dedicated to prostate cancer education, testing, patient support, research and advocacy.

Empower ABA

Empower ABA is a company that provides Applied Behavior Analysis (ABA) therapy services for children with Autism Spectrum Disorder (ASD). Their mission is to empower families by providing the most effective ABA services to ensure that learners with aut...

Nivalis Therapeutics

Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.

JK Associates

JK Associates is a Conshohocken, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.